Immunotherapy in Management of Endometrial Cancer
This online course is a highlight from the 2021 live virtual symposium which was hosted by the Miami Cancer Institute on Women’s Cancer which brought together a distinguished faculty for to focus on the medical management of common and important challenges facing health-care professionals who care for women with cancer.
Breast Surgeons, General Surgeons, Reconstructive Surgeons, Obstetricians and Gynecologists, Oncologists, Medical Oncologists, Physiatrist, Radiation Oncologists, Pathologists, Geneticists, Radiologists, General Practitioners and all other interested healthcare professionals.
- Review existing data to support use of immunotherapy in endometrial cancer.
- Discuss ongoing trials including immunotherapy for the care of women with endometrial cancer.
- Apply relevant testing strategies to guide choice of immunotherapy in endometrial cancer.
- Discuss adverse event management of immunotherapy.
Shannon N. Westin, M.D., MPH
Director, Early Drug Development and Phase 1 Trials
Department of Gynecologic Oncology and Reproductive Medicine
UT MD Anderson Cancer Center,
Shannon N. Westin, M.D., MPH, has indicated that she receives grant/research support from AstraZeneca, Clovis Oncology, Roche/Genentech, GSK/Tesaro, Novartis, Bayer, ArQule, Bio-Path, Cotinga Pharmaceuticals. She is also a consultant for Merck, Pfizer, Eisai, Zentalis, Agenus, and Circulogene. Her presentation will include discussion of off-label or unapproved usage.
John P. Diaz, M.D., has indicated that he is a member of the speakers’ bureau for AstraZeneca and Merck.
Gladys L. Giron, M.D., has indicated that her spouse is a consultant for Stryker.
Nicholas C. Lambrou, M.D., has indicated that he is a consultant for Intuitive, Ethicon and Johnson & Johnson.
Starr K. Mautner, M.D., has indicated that she does not have any relevant relationships with ineligible companies* to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated.
Other individuals involved in planning, content review, approval, or moderating for this educational activity have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.50 AMA PRA Category 1 Credit™
- 0.50 General certificate of attendance
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.